https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-30 / Eur. Urol. 2009 Jun;55(6):1333-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-30 / Eur. Urol. 2009 Jun;55(6):1333-422009-01-30 00:00:002021-11-15 14:46:31Vaccine therapy in patients with renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-28 / Cancer Lett. 2008 Nov;271(2):333-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-28 / Cancer Lett. 2008 Nov;271(2):333-412008-11-28 00:00:002019-02-15 09:16:51Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-01 / J. Immunother. 2008 Oct;31(8):771-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-01 / J. Immunother. 2008 Oct;31(8):771-802008-10-01 00:00:002019-02-15 09:16:52Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-16 / Int. J. Urol. 2008 Aug;15(8):694-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-16 / Int. J. Urol. 2008 Aug;15(8):694-82008-06-16 00:00:002019-02-15 08:48:09Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Methods Mol. Biol. 2008;423:139-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Methods Mol. Biol. 2008;423:139-532008-01-01 00:00:002019-02-15 08:48:15Delivery of whole tumor lysate into dendritic cells for cancer vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-03 / Clin. Immunol. 2007 Dec;125(3):257-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-03 / Clin. Immunol. 2007 Dec;125(3):257-672007-10-03 00:00:002019-02-15 09:16:54Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-01 / Int J Immunopathol Pharmacol 2007 Oct-Dec;20(4):707-17
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-01 / Int J Immunopathol Pharmacol 2007 Oct-Dec;20(4):707-172007-10-01 00:00:002019-02-15 09:16:53Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-01 / J. Immunother. 2007 Oct;30(7):749-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-01 / J. Immunother. 2007 Oct;30(7):749-612007-10-01 00:00:002019-02-15 09:16:55Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-712007-09-01 00:00:002019-02-15 09:16:57Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-92007-09-01 00:00:002019-02-15 09:16:56Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
